eHealth, Inc. (EHTH) · Nov 4, 2026 · Earnings
Miss — EPS $(1.57) vs ~$1.09 consensus; revenue $21.3M vs ~$26.4M consensus
eHealth earnings show sharper cost control and better cash flow, but Q3 revenue and EPS missed consensus as AEP execution becomes critical.
eHealth is in a deliberate 2026 bridge year: rebuilding its Medicare business around a Lifetime Advisory Model, cutting costs sharply, and trying to return to sustainable revenue growth in 2027. That framework was already public before this release, including the 2027 growth target and cost-leverage plan.
The quarter missed the published benchmark, not merely last year’s weak comparison. Q3 revenue was $21.3 million versus a published consensus of roughly $26.4 million, while diluted loss per share was $1.57 versus consensus near $1.09. The company had telegraphed unusually low third-quarter marketing while advisors focused on existing members, so the revenue decline was partly expected; nevertheless, the shortfall was larger than the market’s published estimate.
| Metric | Q3 2026 | Q3 2025 | Consensus |
|---|---|---|---|
| Revenue (Financial Results) | $21.3M (-60%) | $53.9M | $26.4M |
| Diluted EPS (Income Statement) | $(1.57) | $(1.46) | $(1.09) |
| Adjusted EBITDA (Non-GAAP Results) | $(39.9)M | $(34.0)M | |
| Operating cash flow (Cash Flow statement) | $(11.2)M | $(25.3)M | |
| FY26 revenue guidance (FY26 Guidance) | $405M–$445M |
The cost reset is working, but it is not yet producing quarterly profitability. Operating costs fell 29% and Medicare variable marketing expense fell 73%, improving the revenue-to-Medicare-marketing ratio to 3.9x from 2.9x. But the lower-volume strategy left Medicare segment gross loss at $12.7 million versus a $1.2 million loss a year earlier, and adjusted EBITDA deteriorated to a $39.9 million loss.
Cash flow is the clearest positive signal, though it does not erase the earnings miss. Nine-month operating cash flow improved 85% to $19.6 million, and the company maintained its full-year target of breakeven or better operating cash flow. That supports the turnaround plan more than the income statement does, but cash and short-term securities totaled only $88.1 million against $115.5 million of long-term debt, leaving execution and seasonal AEP results important.
The new operating model has early evidence, not yet proof of a revenue inflection. Retention improved for the Q2 Medicare Advantage cohort, ancillary cross-sell nearly doubled year over year, and the new Content Genius system reportedly cut plan-content processing time by more than 90%. Those metrics support the strategic shift toward higher lifetime value, but total approved members fell 47% in the quarter and estimated membership declined 9% year over year, so the model still has to convert engagement into growth.
Bottom line: This was a genuine earnings and revenue miss, but not a wholesale break from the plan because the weak quarter was partly engineered through lower off-season spending. The turnaround remains plausible on cash flow and retention, yet the filing increases the importance of AEP execution and the promised 2027 return to growth.
Q4 2026 results, early March 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!